Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of intraprostatic
injection of Botox for the treatment of men diagnosed with chronic nonbacterial
prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Phase:
Phase 1
Details
Lead Sponsor:
Queen's University
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA Lidocaine onabotulinumtoxinA